Dr. Jordi Bruix, group leader of the Networked Biomedical Research Center for Hepatic and Digestive Diseases (CIBEREHD) at Hospital Clínic and IDIBAP1
A study led by researchers from Hospital Clínic and IDIBAPS defines more precisely the risk of developing colon cancer in patients with serrated pol1
The Translational Reserarch in Hepatic Oncology IDIBAPS group, led by Dr. Josep M. Llovet, in collaboration with Dr. Roser Pinyol and 8 more researc1
Researchers from the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and the Hospital Clínic of Barcelona, in collaboration with qGenomics1
A study published in the New England Journal of Medicine (NEJM) shows that the combination of two drugs (ambrisentan and tadalafil) is more effective1
